Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers

BACKGROUND: : Tranexamic acid (TXA) is an antifibrinolytic drug that reduces surgical blood loss and death due to bleeding after trauma and post-partum haemorrhage. Treatment success is dependant on early intervention and rapid systemic exposure to TXA. The requirement for intravenous (IV) administr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Pharm Sci
Autors principals: Kane, Zoe, Picetti, Roberto, Wilby, Alison, Standing, Joseph F., Grassin-Delyle, Stanislas, Roberts, Ian, Shakur-Still, Haleema
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science B.V 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299544/
https://ncbi.nlm.nih.gov/pubmed/34087356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejps.2021.105893
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars